Company intelligence / Profile preview

Asphalion

Ownership: Private
Employees: ~180
Development stage: Other

Overview

Asphalion is an international consultancy specializing in scientific, safety, and regulatory affairs for the life sciences sector. The company offers expert consulting and operational support throughout all stages of product development—from preclinical through clinical development, registration, and post-marketing—for pharmaceuticals, biologics, advanced therapies (ATMPs), medical devices, and vaccines. It has supported over 1,000 companies in more than 50 countries on over 5,000 projects. Notably contributed to COVID-related projects including securing approval for the BIVERMAX® vaccine in 2023.

Modalities: Small moleculeBiologicAdvanced therapy medicinal products (ATMPs)Medical device (consulting/support only)Vaccine (consulting/support only)
Industry: Consulting

Partnerships

Reguliance (strategic alliance for US FDA regulatory support)

Beyond the preview

Go deeper on Asphalion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asphalion.

Explore the full profile